Lukas Biomedical (ROCO:6814) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6814 Lukas Biomedical Inc ROCO:6814
63 GF Score
Price NT$22.30
GF Value NT$21.01
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Lukas Biomedical Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ROCO:6814
63GF Score
Lukas Biomedical Inc ROCO:6814
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lukas Biomedical (ROCO:6814) Overvalued in 2026?

Based on GuruFocus' analysis, Lukas Biomedical stock appears to be overvalued. The current stock price of NT$22.30 is trading 6.1% above its estimated GF Value™ of NT$21.01. GuruFocus considers Lukas Biomedical to be Fairly Valued.

Key valuation signals for ROCO:6814:

  • Short Ratio:
  • GF Value™: NT$21.01 vs. price of NT$22.30 (6.1% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the ROCO:6814 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lukas Biomedical Business Description

Address No. 14-16, Zhongxiao Road, 1st Floor, Banqiao District, New Taipei City, TWN, 220
Lukas Biomedical Inc. is engaged in researching and developing immunotherapy for cancer treatment technologies. The company's main business activities include developing immunocellular therapy, leasing and selling medical equipment, and selling biotech beauty products.
63GF Score

Get the complete analysis for ROCO:6814

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.30
Price
NT$21.01
GF Value